Atlas Trials

Begin With The Right Patients With Dual-Inhibition Action Therapy Through Vytorin for Newly Diagnosed Dyslipidemia Patients (0653A-172)(COMPLETED)

Clinical trial NCT00654628 · COMPLETED

Trial details

NCT number
NCT00654628
Sponsor
Organon and Co
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Hypercholesterolemia
Start date
2007-08-01
Primary completion
2009-07-01
Enrollment
173

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.